300255 常山药业
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)0.242-14.789-50.9360.5727.896
总资产报酬率 ROA (%)0.083-5.471-23.3290.3124.785
投入资产回报率 ROIC (%)0.091-5.997-25.3300.3345.154

边际利润分析
销售毛利率 (%)23.10016.10322.50244.42158.181
营业利润率 (%)1.127-24.645-86.9460.8758.827
息税前利润/营业总收入 (%)9.418-15.118-80.7374.81011.218
净利润/营业总收入 (%)0.629-25.614-88.4940.4357.792

收益指标分析
经营活动净收益/利润总额(%)-106.27584.07548.289164.29596.535
价值变动净收益/利润总额(%)0.000-12.939-0.0010.0000.000
营业外收支净额/利润总额(%)15.1671.1810.436-12.896-0.610

偿债能力分析
流动比率 (X)0.8210.9091.1852.1801.966
速动比率 (X)0.2960.2800.3290.8200.648
资产负债率 (%)66.13566.04460.84649.40240.805
带息债务/全部投入资本 (%)59.94459.45654.90444.55835.746
股东权益/带息债务 (%)62.36263.15079.332121.839176.804
股东权益/负债合计 (%)52.06152.30264.777102.558144.909
利息保障倍数 (X)1.164-1.539-12.2521.1924.590

营运能力分析
应收账款周转天数 (天)100.99580.28377.32453.40241.278
存货周转天数 (天)604.778630.661671.176653.827605.008